← Back
$MNPR All transactions

Monopar Therapeutics

▼ SELL

$ Value

$35.0M

Shares

550,229

Price

$64

Filed

Sep 26

Insider

Name

Tactic Pharma LLC

Title

CIK

0001727357

Roles

10% Owner

Transaction Details

Transaction Date

2025-09-24

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

272,026

Footnotes

This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc.

Filing Info

Accession No.

0001437749-25-029925

Form Type

4

Issuer CIK

0001645469

Tactic Pharma LLC's History

Date Ticker Type Value
2025-09-24 MNPR $35.0M

Other Insiders at MNPR (90d)

Insider Bought Sold Last
Robinson Chandler
Chief Executive Officer
2026-03-31
Rodriguez Susan
CCSO
2026-03-02
Cittadine Andrew
Chief Operating Officer
2026-03-31